Kidney Transplant Research Today is a free monthly online journal that collates and summarizes the latest research about Kidney Transplant, including details on risks, prognosis, procedure, surgery, organ donation.

Volume 2 (2005), Issue 9 (September)

1. Secondary hyperparathyroidism is associated with vitamin D receptor polymorphism and bone density after renal transplantation.
   Biomed Pharmacother, 59(7): 402-7. [Abstract] [Full-text]
2. Disappearance of HCV after cessation of immunosuppression in a patient with ulcerative colitis and renal transplantation.
   J Gastroenterol, 40(8): 848-53. [Abstract] [Full-text]
3. Real-time polymerase chain reaction and laser capture microdissection for the diagnosis of BK virus infection in renal allografts.
   Am J Clin Pathol, 124(4): 537-42. [Abstract] [Full-text]
4. Pancreatico-renal composite transplant: a new technique designed to decrease pancreatic graft thrombosis.
   Clin Transplant, 19(5): 690-3. [Abstract] [Full-text]
5. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
   Clin Transplant, 19(5): 668-73. [Abstract] [Full-text]
6. The effects of renal transplantation on peripheral blood dendritic cells.
   Clin Transplant, 19(5): 659-67. [Abstract] [Full-text]
7. Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation.
   Clin Transplant, 19(5): 638-43. [Abstract] [Full-text]
8. Surgical management of spinal disease in renal recipients.
   Clin Transplant, 19(5): 632-7. [Abstract] [Full-text]
9. Is alanine aminotransferase a good marker of histologic hepatic damage in renal transplant patients with hepatitis C virus infection?
   Clin Transplant, 19(5): 622-5. [Abstract] [Full-text]
10. Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus.
    Clin Transplant, 19(5): 616-21. [Abstract] [Full-text]
11. Concentration-controlled use of sirolimus associated with reduced exposure of cyclosporine in black recipients of primarily living renal allograft donors: 12-month results.
    Clin Transplant, 19(5): 607-15. [Abstract] [Full-text]
12. Older living donors provide excellent quality kidneys: a single center experience (older living donors).
    Clin Transplant, 19(5): 600-6. [Abstract] [Full-text]
13. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
    Clin Transplant, 19(5): 573-80. [Abstract] [Full-text]
14. Necrotizing fasciitis during de novo minimal change nephrotic syndrome in a kidney transplant recipient.
    Transpl Infect Dis, 7(2): 89-92. [Abstract] [Full-text]
15. A renal transplant patient with intractable hiccups and review of the literature.
    Transpl Infect Dis, 7(2): 86-8. [Abstract] [Full-text]
16. Cellulitis as a manifestation of miliary tuberculosis in a renal transplant recipient.
    Transpl Infect Dis, 7(2): 80-5. [Abstract] [Full-text]
17. Mycobacterium avium complex infection in kidney transplant patients.
    Transpl Infect Dis, 7(2): 75-9. [Abstract] [Full-text]
18. Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient.
    Transpl Infect Dis, 7(2): 71-4. [Abstract] [Full-text]
19. Localized cecal zygomycosis following renal transplantation.
    Transpl Infect Dis, 7(2): 68-70. [Abstract] [Full-text]
20. Comparing cytomegalovirus prophylaxis in renal transplantation: single center experience.
    Transpl Infect Dis, 7(2): 63-7. [Abstract] [Full-text]
21. Occult hepatitis B in renal transplant patients.
    Transpl Infect Dis, 7(2): 51-6. [Abstract] [Full-text]
22. Cancer incidence after immunosuppressive treatment following kidney transplantation.
    Crit Rev Oncol Hematol, 56(1): 71-85. [Abstract] [Full-text]
23. Massive immune hemolysis caused by anti-D after dual kidney transplantation.
    Am J Transplant, 5(10): 2586-9. [Abstract] [Full-text]
24. Ultra-late antibody-mediated rejection 30 years after a living-related renal allograft.
    Am J Transplant, 5(10): 2576-81. [Abstract] [Full-text]
25. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment.
    Am J Transplant, 5(10): 2570-5. [Abstract] [Full-text]
26. Predictors and risk factors for recurrent scleroderma renal crisis in the kidney allograft: case report and review of the literature.
    Am J Transplant, 5(10): 2565-9. [Abstract] [Full-text]
27. Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction--long-term results.
    Am J Transplant, 5(10): 2539-48. [Abstract] [Full-text]
28. Comparison of sirolimus with low-dose tacrolimus versus sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation.
    Am J Transplant, 5(10): 2531-8. [Abstract] [Full-text]
29. Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients.
    Am J Transplant, 5(10): 2521-30. [Abstract] [Full-text]
30. Laparoscopic versus open renal procurement for pediatric recipients of living donor renal transplantation.
    Am J Transplant, 5(10): 2514-20. [Abstract] [Full-text]
31. A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation.
    Am J Transplant, 5(10): 2496-503. [Abstract] [Full-text]
32. Measuring surgical recovery: the study of laparoscopic live donor nephrectomy.
    Am J Transplant, 5(10): 2489-95. [Abstract] [Full-text]
33. Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients.
    Am J Transplant, 5(10): 2479-88. [Abstract] [Full-text]
34. Prednisone-free maintenance immunosuppression-a 5-year experience.
    Am J Transplant, 5(10): 2473-8. [Abstract] [Full-text]
35. Predicting subsequent decline in kidney allograft function from early surveillance biopsies.
    Am J Transplant, 5(10): 2464-72. [Abstract] [Full-text]
36. Characterization of waiting times in a simulation of kidney paired donation.
    Am J Transplant, 5(10): 2448-55. [Abstract] [Full-text]
37. Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies.
    Am J Transplant, 5(10): 2433-40. [Abstract] [Full-text]
38. Long-term consequences of live kidney donation follow-up in 93% of living kidney donors in a single transplant center.
    Am J Transplant, 5(10): 2417-24. [Abstract] [Full-text]
39. Screening to prevent polyoma virus nephropathy: a medical decision analysis.
    Am J Transplant, 5(10): 2410-6. [Abstract] [Full-text]
40. Anti-CD28 antibody-induced kidney allograft tolerance related to tryptophan degradation and TCR class II B7 regulatory cells.
    Am J Transplant, 5(10): 2339-48. [Abstract] [Full-text]
41. Prevention of chronic allograft nephropathy with vitamin D.
    Transpl Int, 18(10): 1175-86. [Abstract] [Full-text]
42. Evolution of tacrolimus blood levels and concentration-dose ratios in patients who develop new onset diabetes mellitus after kidney transplantation.
    Transpl Int, 18(10): 1152-7. [Abstract] [Full-text]
43. Preoperative evaluation of living kidney donors using multirow detector computed tomography: comparison with digital subtraction angiography and intraoperative findings.
    Transpl Int, 18(10): 1134-41. [Abstract] [Full-text]
44. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review.
    Transpl Int, 18(10): 1121-33. [Abstract] [Full-text]
45. Pre-transplant plasma and cellular levels of CD44 correlate with acute renal allograft rejection.
    Nephrol Dial Transplant, 20(10): 2248-54. [Abstract] [Full-text]
46. A novel biological assay to detect the active form of TGF-beta in urine to monitor renal allograft rejection.
    Kidney Int, 68(4): 1875-83. [Abstract] [Full-text]
47. Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status.
    Kidney Int, 68(4): 1866-74. [Abstract] [Full-text]
48. BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients.
    Kidney Int, 68(4): 1834-9. [Abstract] [Full-text]
49. Preconditioning of the distal tubular epithelium of the human kidney precedes nephrocalcinosis.
    Kidney Int, 68(4): 1643-7. [Abstract] [Full-text]
50. LT, VP1 and TCR-BKV sequence analysis in a patient with post-transplant BKV nephropathy associated with EBV-related PTLD.
    Pediatr Nephrol, 20(10): 1506-9. [Abstract] [Full-text]
51. Questionnaire-based evaluation of gastrointestinal disorders in de novo renal-transplant patients receiving either mycophenolate mofetil or enteric-coated mycophenolate sodium.
    Nephrol Dial Transplant, 20(10): 2231-6. [Abstract] [Full-text]
52. Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates.
    Nephrol Dial Transplant, 20(10): 2207-14. [Abstract] [Full-text]
53. Leukocyte phenotype and function predicts infection risk in renal transplant recipients.
    Nephrol Dial Transplant, 20(10): 2226-30. [Abstract] [Full-text]
54. Do dialysis- and transplantation-related medical factors affect perceived health status?
    Nephrol Dial Transplant, 20(10): 2153-8. [Abstract] [Full-text]
55. Oro-dental health in children with chronic renal failure and after renal transplantation: a clinical review.
    Pediatr Nephrol, 20(10): 1388-94. [Abstract] [Full-text]
56. Cross-sectional assessment of the effect of kidney and kidney-pancreas transplantation on resting left ventricular energy metabolism in type 1 diabetic-uremic patients: a phosphorous-31 magnetic resonance spectroscopy study.
    J Am Coll Cardiol, 46(6): 1085-92. [Abstract] [Full-text]
57. More than 500 consecutive laparoscopic donor nephrectomies without conversion or repeated surgery.
    Arch Surg, 140(9): 835-9; discussion 839-40. [Abstract] [Full-text]
58. TGFbeta-1 and the development of chronic graft nephropathy: relative roles of gene, mRNA and protein.
    Ann R Coll Surg Engl, 87(5): 326-30. [Abstract] [Full-text]
59. Porcine dermal collagen graft in pediatric renal transplantation.
    Pediatr Transplant, 9(5): 627-9. [Abstract] [Full-text]
60. Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation.
    Pediatr Transplant, 9(5): 622-6. [Abstract] [Full-text]
61. Hypertension and ace gene insertion/deletion polymorphism in pediatric renal transplant patients.
    Pediatr Transplant, 9(5): 612-7. [Abstract] [Full-text]
62. Tissue viral DNA is associated with chronic allograft nephropathy.
    Pediatr Transplant, 9(5): 598-603. [Abstract] [Full-text]
63. Results of one-year follow-up of steroid-free immunosuppression in pediatric renal transplant patients.
    Pediatr Transplant, 9(5): 589-97. [Abstract] [Full-text]
64. Neurophysiologic changes in live related kidney transplant children and adolescents.
    Pediatr Transplant, 9(5): 579-83. [Abstract] [Full-text]
65. Caregiver attitudes towards gastrostomy removal after renal transplantation.
    Pediatr Transplant, 9(5): 574-8. [Abstract] [Full-text]
66. Limited sampling strategy for cyclosporine (Neoral) area under the curve monitoring in pediatric kidney transplant recipients.
    Pediatr Transplant, 9(5): 566-73. [Abstract] [Full-text]
67. Rates of completion of the medical evaluation for renal transplantation.
    Am J Kidney Dis, 46(4): 734-45. [Abstract] [Full-text]
68. De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications.
    Am J Kidney Dis, 46(4): 720-33. [Abstract] [Full-text]
69. Simultaneous pancreas-kidney transplantation in a large multicenter study: surgical complications.
    Transplant Proc, 37(6): 2859-60. [Abstract] [Full-text]
70. Simultaneous pancreas-kidney transplantation: analysis of rejection.
    Transplant Proc, 37(6): 2856-8. [Abstract] [Full-text]
71. Corticosteroid withdrawal in simultaneous pancreas-kidney transplantation: a 3-year report.
    Transplant Proc, 37(6): 2853-5. [Abstract] [Full-text]
72. Metabolic assessment after simultaneous pancreas-kidney transplantation.
    Transplant Proc, 37(6): 2851-2. [Abstract] [Full-text]
73. Cytomegalovirus infection in simultaneous pancreas-kidney transplantation.
    Transplant Proc, 37(6): 2848-50. [Abstract] [Full-text]
74. Effect of HLA matching in simultaneous pancreas-kidney transplantation.
    Transplant Proc, 37(6): 2846-7. [Abstract] [Full-text]
75. Tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: the EURO-SPK 3-year results.
    Transplant Proc, 37(6): 2843-5. [Abstract] [Full-text]
76. Immunosuppressive drugs after simultaneous pancreas-kidney transplantation.
    Transplant Proc, 37(6): 2840-2. [Abstract] [Full-text]
77. Renal artery aneurysm secondary to Candida albicans in four kidney allograft recipients.
    Transplant Proc, 37(6): 2834-6. [Abstract] [Full-text]
78. Sirolimus-associated acute respiratory distress syndrome in a renal transplant recipient.
    Transplant Proc, 37(6): 2830-1. [Abstract] [Full-text]
79. Is sirolimus responsible for proteinuria?
    Transplant Proc, 37(6): 2828-9. [Abstract] [Full-text]
80. Infectious complications in kidney transplant recipients: a single-center experience.
    Transplant Proc, 37(6): 2823-5. [Abstract] [Full-text]
81. Cost of renal transplant in Belgium.
    Transplant Proc, 37(6): 2819-20. [Abstract] [Full-text]
82. Preemptive renal transplantation in adults.
    Transplant Proc, 37(6): 2817-8. [Abstract] [Full-text]
83. Combined use of tacrolimus and sirolimus in de novo renal transplant patients: current data.
    Transplant Proc, 37(6): 2813-6. [Abstract] [Full-text]
84. Impact of homocysteinemia on long-term renal transplant survival.
    Transplant Proc, 37(6): 2784-8. [Abstract] [Full-text]
85. Conversion to sirolimus in a population of kidney and kidney-pancreas transplant recipients.
    Transplant Proc, 37(6): 2777-80. [Abstract] [Full-text]
86. Progression of the renal graft: treatment of acute rejection based on a biopsy against a presumptive diagnosis.
    Transplant Proc, 37(6): 2775-6. [Abstract] [Full-text]
87. Pediatric renal transplantation: comparative study with renal transplantation in the adult population.
    Transplant Proc, 37(6): 2771-4. [Abstract] [Full-text]
88. Nutritional status and body composition evolution in early post-renal transplantation: is there a female advantage?
    Transplant Proc, 37(6): 2765-70. [Abstract] [Full-text]
89. Ureteric lesions detected in normally functioning kidney allografts: risk factors and clinical implications.
    Transplant Proc, 37(6): 2762-4. [Abstract] [Full-text]
90. Calcineurin inhibitor-free immunosuppression in renal transplantation.
    Transplant Proc, 37(6): 2759-61. [Abstract] [Full-text]
91. Immunosuppression with antithymocyte globulin in renal transplantation: better long-term graft survival.
    Transplant Proc, 37(6): 2755-8. [Abstract] [Full-text]
92. Immunoglobulin G-positive in B-cell cross-match decreases kidney allograft survival.
    Transplant Proc, 37(6): 2753-4. [Abstract] [Full-text]
93. Clinical relevance of low levels of preformed alloantibodies detected by flow cytometry in the first year post-kidney transplantation.
    Transplant Proc, 37(6): 2750-2. [Abstract] [Full-text]
94. Hand-assisted laparoscopic nephrectomy versus transperitoneal anterior approach in living donors for renal transplantation.
    Transplant Proc, 37(6): 2748-9. [Abstract] [Full-text]
95. Incidence of delayed graft function in cadaveric kidney transplants in Brazil: a multicenter analysis.
    Transplant Proc, 37(6): 2746-7. [Abstract] [Full-text]
96. Histological alterations found in the ureter during organ preservation and early phases of renal transplantation.
    Transplant Proc, 37(6): 2743-5. [Abstract] [Full-text]
97. Do elderly patients deserve a kidney graft?
    Transplant Proc, 37(6): 2737-42. [Abstract] [Full-text]
98. Assessment of an LC-MS method for plasma quantification of the new immunosuppressant FK778 through comparison with HPLC-UV.
    Transplant Proc, 37(6): 2722-7. [Abstract] [Full-text]
99. Surgical complications are the main cause of pancreatic allograft loss in pancreas-kidney transplant recipients.
    Transplant Proc, 37(6): 2651-3. [Abstract] [Full-text]
100. Neoral versus prograf in simultaneous pancreas-kidney transplantation with portal venous drainage: three-year results of a single-center, open-label, prospective, randomized pilot study.
     Transplant Proc, 37(6): 2641-3. [Abstract] [Full-text]
101. Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients.
     Transplant Proc, 37(6): 2574-5. [Abstract] [Full-text]
102. Kidney transplantation from hepatitis C virus-positive donors into hepatitis C virus-positive recipients: a safe way to expand the donor pool?
     Transplant Proc, 37(6): 2571-3. [Abstract] [Full-text]
103. Malignancies after kidney transplantation.
     Transplant Proc, 37(6): 2529-31. [Abstract] [Full-text]
104. Cutaneous manifestations in Italian kidney transplant recipients.
     Transplant Proc, 37(6): 2527-8. [Abstract] [Full-text]
105. Double J stent with antireflux device in the prevention of short-term urological complications after cadaveric kidney transplantation: single-center prospective randomized study.
     Transplant Proc, 37(6): 2525-6. [Abstract] [Full-text]
106. Percutaneous renal artery embolization of nonfunctioning allograft: preliminary experience.
     Transplant Proc, 37(6): 2523-4. [Abstract] [Full-text]
107. Urologic complications in kidney transplantation.
     Transplant Proc, 37(6): 2521-2. [Abstract] [Full-text]
108. Urological complications in kidney transplantation: ureterocystostomy versus uretero-ureterostomy.
     Transplant Proc, 37(6): 2518-20. [Abstract] [Full-text]
109. The treatment of fistulae and ureteral stenosis after kidney transplantation.
     Transplant Proc, 37(6): 2516-7. [Abstract] [Full-text]
110. Advantages of short-time ureteric stenting for prevention of urological complications in kidney transplantation: an 18-year experience.
     Transplant Proc, 37(6): 2511-5. [Abstract] [Full-text]
111. Acute diverticulitis with colon perforation in renal transplantation.
     Transplant Proc, 37(6): 2507-10. [Abstract] [Full-text]
112. Cytomegalovirus infection with multiple colonic perforations in a renal transplant recipient.
     Transplant Proc, 37(6): 2504-6. [Abstract] [Full-text]
113. Infectious complications in the renal transplant recipient.
     Transplant Proc, 37(6): 2502-3. [Abstract] [Full-text]
114. Immunosuppression in renal transplantation: viral diseases and chronic allograft nephropathy.
     Transplant Proc, 37(6): 2500-1. [Abstract] [Full-text]
115. Infectious complications in renal transplant recipients.
     Transplant Proc, 37(6): 2497-9. [Abstract] [Full-text]
116. Nosocomial infection in kidney transplant recipients: a retrospective analysis of a single-center experience.
     Transplant Proc, 37(6): 2495-6. [Abstract] [Full-text]
117. Venous thromboembolism in renal transplant recipients: high rate of recurrence.
     Transplant Proc, 37(6): 2493-4. [Abstract] [Full-text]
118. Homocysteine-lowering therapy and carotid intima-media thickness in renal transplant recipients.
     Transplant Proc, 37(6): 2491-2. [Abstract] [Full-text]
119. Abdominal aortic aneurysm in renal transplant recipients.
     Transplant Proc, 37(6): 2488-90. [Abstract] [Full-text]
120. Effects of successful renal transplantation on left ventricular mass.
     Transplant Proc, 37(6): 2485-7. [Abstract] [Full-text]
121. Predictive factors in chronic allograft nephropathy.
     Transplant Proc, 37(6): 2482-4. [Abstract] [Full-text]
122. Comparison of oblique versus hockey-stick surgical incision for kidney transplantation.
     Transplant Proc, 37(6): 2479-81. [Abstract] [Full-text]
123. Cytotoxic molecule mRNA expression in chronically rejected human kidney allografts.
     Transplant Proc, 37(6): 2476-8. [Abstract] [Full-text]
124. Dopamine "renal dose" versus fenoldopam mesylate to prevent ischemia-reperfusion injury in renal transplantation.
     Transplant Proc, 37(6): 2474-5. [Abstract] [Full-text]
125. Value of intraoperative resistive index in kidney transplant.
     Transplant Proc, 37(6): 2472-3. [Abstract] [Full-text]
126. Kidney transplantation combined with other organs: experience of Bologna s. Orsola hospital.
     Transplant Proc, 37(6): 2469-71. [Abstract] [Full-text]
127. Kidney transplantation from hepatitis B surface antigen-positive donors into hepatitis B surface antigen-positive recipients: preliminary findings.
     Transplant Proc, 37(6): 2467-8. [Abstract] [Full-text]
128. Impact of mycophenolate mofetil dose posttransplantation on 12-month renal function: analysis of the MOST database.
     Transplant Proc, 37(6): 2464-6. [Abstract] [Full-text]
129. Multivariate analysis of factors affecting patient and graft survival after renal transplant.
     Transplant Proc, 37(6): 2461-3. [Abstract] [Full-text]
130. Anti-HLA antibodies in kidney transplanted patients.
     Transplant Proc, 37(6): 2459-60. [Abstract] [Full-text]
131. Kidney transplantation from elderly donors: a prospective randomized study comparing celsior and UW solutions.
     Transplant Proc, 37(6): 2454-5. [Abstract] [Full-text]
132. Kidney transplantation from cadaveric donors unsuitable for other centers and older than 60 years of age.
     Transplant Proc, 37(6): 2451-3. [Abstract] [Full-text]
133. Technical problems in living donor transplantation.
     Transplant Proc, 37(6): 2449-50. [Abstract] [Full-text]
134. Living donor kidney transplant: medicolegal and insurance aspects.
     Transplant Proc, 37(6): 2439-44. [Abstract] [Full-text]
135. Ethical considerations on kidney transplantation from living donors.
     Transplant Proc, 37(6): 2436-8. [Abstract] [Full-text]
136. Waiting list for kidney transplants.
     Transplant Proc, 37(6): 2419-20. [Abstract] [Full-text]
137. Subtotal parathyroidectomy with thymectomy for autonomous hyperparathyroidism after renal transplantation.
     Br J Surg, 92(10): 1282-7. [Abstract] [Full-text]
138. Exposure to the field of renal transplantation during undergraduate medical education in the UK.
     BMC Med Educ, 5: 32. [Abstract] [Full-text]
139. An unusual case of posttransplant peritoneal primary effusion lymphoma with T-cell phenotype in a HIV-negative female, not associated with HHV-8.
     Pathol Oncol Res, 11(3): 178-81. [Abstract] [Full-text]
140. Strategies to increase living donor kidney transplants.
     Urology, 66(5): 43-6. [Abstract] [Full-text]

© 2004-2008 Kidney Transplant Research Today. All Rights Reserved.